Please note that the table below may need to be scrolled horizontally or vertically in order to view all information, depending on your device.
| Medication | Indication | Anything of note |
| Apprepitant | Pre SACT and post SACT radiotherapy | For high risk emesis SACT. |
| Cyclizine | Rescue anti-emetic |
Slows GI peristalsis therefore avoid using with metoclopramide. Centrally acting antihistamine. |
| Dexamethasone | Pre and post SACT radiotherapy | Steroid |
| Fosapprepitant | Pre SACT | Given IV; for use in patients unable to swallow aprepitant of Akynzeo. |
| Granisetron |
Pre and post SACT Used pre and during radiotherapy |
5HT3 antagonist Common side effects: headaches and constipation. |
| Levomepromazine |
Rescue antiemetic and often used in continuous subcutaneous infusions |
Centrally acting antiemetic. Can cause sedation and hypotension. |
| Lorazapam | Anxiety/ anticipatory nausea |
Anxiolytic Caution in patients with long term nausea due to dependence risk. |
| Metoclopramide |
Used for patients on SACT Radiotherapy |
Prokinetic therefore avoid in patients with diarrhoea or on cyclizine. Also avoid in patients who have Parkinson's disease. |
| Olanzapine | Rescue antiemetic for patients on high risk SACT |
Centrally acting Causes sedation Avoid in patients with epilepsy |
| Ondansetron | SACT or Radiotherapy |
5HT3 antagonist Melts formulation available for patients unable to swallow. |
| Prochlorperazine | Normally used as a second or third line anti-emetic |
May cause drowsiness Buccal form can be used for patients who are vomiting. |
Further treatment guidance / reference documents:
Nausea and vomiting | Right Decisions
Only accessible from an NHS Lothian Device:
Anti-emetic Guidelines for Radiotherapy Treatment ![]()